Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4BDSI

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NALDEMEDINE TOSYLATE

US Patent Number : RE46375

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208854

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2026-10-05

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NALDEMEDINE TOSYLATE

US Patent Number : RE46365

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208854

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-01-11

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NALDEMEDINE TOSYLATE

US Patent Number : 9108975

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208854

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-11

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NALDEMEDINE TOSYLATE

US Patent Number : 10952968

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208854

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-13

blank